Chemical Compound

5-HT1A/5-HT1B agonist and 5-HT2C antagonist (ADHD), PsychoGenics/ReqMed Company

CAS Registry Number 98224-03-4
5-HT1A/5-HT1B agonist and 5-HT2C antagonist (ADHD), PsychoGenics/ReqMed Company 结构式
Primary record

5-HT1A/5-HT1B agonist and 5-HT2C antagonist (ADHD), PsychoGenics/ReqMed Company

库存
6,921 克
纯度
99.8 %
CAS
98224-03-4

化合物标识与属性

CAS
98224-03-4
PubChem CID
65853
SMILES
C1CN(CCN1)C2=C3C(=CC=C2)OCCO3
Canonical SMILES
c1cc2c(c(N3CCNCC3)c1)OCCO2

名称与同义词

  • Eltoprazine
  • Eltoprazina
  • Eltoprazine hydrochloride
  • Eltoprazinum
  • eltoprazinehcl
  • Eltoprazine [INN]
  • Eltoprazine HCl
  • Eltoprazinum [Latin]
  • 98224-03-4
  • Eltoprazina [Spanish]
  • 1-(2,3-dihydro-1,4-benzodioxin-5-yl)piperazine
  • ELTOPRAZINE [MI]
  • RefChem:136558
  • 1-(2,3-Dihydrobenzo[b][1,4]dioxin-5-yl)piperazine
  • D06FKC
  • 1-(1,4-Benzodioxan-5-yl)piperazine
  • 98206-09-8
  • CHEMBL282614
  • ELTOPRAZINE [MART.]
  • UNII-5275JY4PKD
  • MFCD00868056
  • DTXSID5048425
  • DU-28853
  • SCHEMBL177715
  • 1-(2,3-Dihydro-benzo[1,4]dioxin-5-yl)-piperazine
  • WVLHGCRWEHCIOT-UHFFFAOYSA-N
  • AC1L243T
  • C12H16N2O2
  • orb1692272
  • SCHEMBL2203340
  • ZINC1347
  • N-(benzodioxan-5-yl)piperazine
  • 510M006KO6
  • DTXCID3028398
  • UNII-510M006KO6
  • CTK8C4602
  • CHEBI:234413
  • BCP19313
  • CID65853
  • C12-H16-N2-O2.Cl-H
  • 1-(1,4-benzodioxan-5-yl)piperazin
  • AM1234
  • ANW-72449
  • BDBM50035057
  • EBC-71126
  • PDSP1_000561
  • PDSP2_000559
  • DU 28853
  • AKOS016007669
  • 1-(1,4-benzodioxan-5-yl)-piperazine
  • 5-piperazino-2,3-dihydro-1,4-benzodioxin
  • CS-3216
  • DB12883
  • FE22657
  • SB16767
  • NCGC00159533-01
  • AJ-08010
  • BC224842
  • DU 28893
  • HY-16687
  • J258.510C
  • LS-178371
  • TX-011454
  • B4708
  • NS00068070
  • 1-(2,3-dihydrobenzo[1,4]dioxin-5-yl)piperazine
  • 4-(2,3-dihydrobenzo[1,4]dioxin-5-yl)piperazine
  • 5-(piperazin-1-yl)-2,3-dihydro-1,4-benzodioxin
  • (2,3-dihydro[1,4]benzodioxin-5-yl)piperazine
  • 1-[(2,3-dihydro-1,4-benzodioxin)-5-yl]piperazine
  • H11026
  • EN300-1839382
  • Piperazine, 1-(2,3-dihydro-1,4-benzodioxin-5-yl)-
  • 1-(2,3-dihydro-1,4-benzodioxan-5-yl)piperazine
  • A858569
  • L000982
  • N-(2,3-dihydrobenzo[1,4]dioxin-5-yl)piperazine
  • 1-(2,3-dihydrobenzo[1,4]dioxin-5-yl)-piperazine
  • 4-(2,3-dihydrobenzo[1,4]dioxin-5-yl)-piperazine
  • Q5367896
  • 4-(2,3-dihydro-1,4-benzodioxin-5-yl)-1-piperazine
  • 4-(2,3-dihydro-benzo[1,4]dioxin-5-yl)-piperazine
  • BRD-K86171477-001-01-3
  • BRD-K86171477-001-02-1
  • BRD-K86171477-001-03-9
  • BRD-K86171477-003-01-9
  • Piperazine,1-(2,3-dihydro-1,4-benzodioxin-5-yl)-
  • Z2044804716
  • Piperazine derivative (ADHD), PsychoGenics/ReqMed Company
  • 1-(2,3-dihydro-1,4-benzodioxin-5-yl)piperazine hydrochloride
  • (eltoprazine)1-(2,3-Dihydro-benzo[1,4]dioxin-5-yl)-piperazine
  • 1-(2,3-Dihydrobenzo[b][1,4]dioxin-5-yl)piperazine hydrochloride
  • 1-(2,3-DIHYDRO-1,4-BENZODIOXIN-5-YL)-PIPERAZINE HYDROCHLORIDE
  • 5-HT1A/5-HT1B agonist and 5-HT2C antagonist (ADHD), PsychoGenics/ReqMed Company
  • 872-479-1